Sunny BioDiscovery, Inc. is a growing biotech company specialized in the isolation of dermatological and wound healing products from natural sources.
One of the greatest opportunities of the dawn of the XXI century is the increasing understanding of the molecular mechanisms of human aging and age-associated diseases. Also, more and more insight is gained into the reparative processes occurring in human bodies, such as periodontal restoration, skin regeneration and wound healing. It appears that these processes have several pathways in common, such as control of oxidative stress and macromolecular glycation as well as vascular remodeling. This makes of angiogenesis (the growth of blood vessels) and extracellular matrix regulation broad therapeutic targets for the treatment of a vast array of conditions including cancer, aged & diabetic skin and wounds.
Although the concepts of extracellular matrix- and angio- modulatory therapies are relatively new, the remedies targeting these processes have been unsuspectedly used for thousands of years by traditional healers, in the form of ill-defined herbal extracts and soups. Sunny BioDiscovery is leveraging its solid expertise in traditional-medicinal and basic biomedical fields, to identify and validate angiomodulatory and other drug- candidates from plants with proven therapeutical activity. Our portfolio of innovative products includes angio- and glycation- modulatory, collagen-stimulatory, metalloproteinase-inhibitory and anti-oxidant compounds.
Thus, in this new era of Integrative Medicine, Sunny BioDiscovery is set to fill the gap between modern medical needs and the therapeutic potential of traditional herbal wisdom. For more information about our science, integrated research products and testing services, click on the corresponding tabs.
